Novartis AG (NVS) stock
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$159.13−1.07 (-0.67%)
Close on Nov 17, 2026Market cap $303.64BP/E 22.3Yield –
Novartis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Novartis
Novartis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?